Sinopharm Tech Plans to Set Up Face Masks Testing Laboratory, Aiming to Enhance Quality Control

HONG KONG, Sept. 2, 2020 /PRNewswire/ -- Sinopharm Tech Holdings Limited ("Sinopharm Tech" and its subsidiaries, together, the "Group", stock code: 8156) is pleased to announce that the Group has signed a management contract ("Management Agreement") with Intertek Testing Services Hong Kong Limited ("Intertek Hong Kong") to establish a long term business relationship ("Cooperation"), with the aims of setting up and operating a face masks testing laboratory ("Testing Laboratory") in the name of Intertek Hong Kong. Intertek Group plc is a leading Total Quality Assurance provider to industries worldwide with a network of more than 1,000 laboratories and offices and over 46,000 people in more than 100 countries.

In response to Sinopharm Tech's rapid business expansion needs and the expansion in the production of personal protective equipment, the Group and Intertek Hong Kong will be working together to establish a Testing Laboratory in Hong Kong. This Testing Laboratory will provide the American Society for Testing and Materials ASTM F2100 standard and European Committee for Standardization EN 14683 standard testing services under ISO/IEC 17025 accreditation. As part of this Cooperation, this Testing Laboratory will be operated independently by Intertek Hong Kong. Intertek Hong Kong will be fully responsible for the design, setup, accreditation, operation management and maintenance of the Testing Laboratory. The Cooperation with an international professional testing team not only allows our Testing Laboratory to obtain world-class testing professional experience and technical know-how, this will also speed up the time for providing accredited testing services to the public.

The Group has successively established 8 cleanrooms and more than 20 mask production lines in Mainland China and Hong Kong since February 2020. Recently, the Group has signed product sales agreements to purchase around 337 tons of Meltblown Fabric within this year, the said amount of fabric is adequate of producing more than 300 million masks. With the increasing demand for risk-based quality assurance, this Testing Laboratory will safeguard our production quality standards across the whole production process, from the testing of raw materials to finished products, allowing us to supply high quality and compliant products to the market.

Through this Cooperation, the Group is committed to making this Testing Laboratory an authoritative and accredited testing laboratory in Hong Kong, providing a full set of testing services based on the American Society for Testing and Materials ASTM F2100 standard and European Committee for Standardization EN 14683 standard. In addition to providing quality testing and technical support for the Group, this Testing Laboratory will also provide world-class testing services to other Hong Kong mask & personal protection equipment manufacturers, thus working with the industry to improve product quality and be the quality gatekeeper for Hong Kong citizens.

Mr. CHAN Ting, Executive Director and Chief Executive Officer of Sinopharm Tech, said, "It is an honor to work closely with Intertek, a world-class quality assurance organization. I have full confidence that the laboratory, under their expertise, will become a top-class globally recognized laboratory. This cooperation will help our company to constantly improve our product quality and Intertek will be an important partner in helping us develop our new products."

About Intertek Testing Services Hong Kong Limited

Intertek Hong Kong is part of Intertek Group plc (ITRK:LN) – a leading Total Quality Assurance provider to industries worldwide. Intertek's network of more than 1,000 laboratories and offices and over 46,000 people in more than 100 countries delivers innovative and bespoke Assurance, Testing, Inspection and Certification solutions for its customers' operations and supply chains.

About Sinopharm Tech Holdings Limited

Sinopharm Tech Holdings Limited is a company that provides integrated solutions on lottery and "Internet Plus", as well as the manufacturing of personal protective equipment. In 2019, the Group successfully introduced Sinopharm Traditional Chinese Medicine Overseas Holdings Limited, a wholly-owned subsidiary of Sinopharm Traditional Chinese Medicine Co. Ltd, as one of the major strategic shareholders.

The Group has been involved in China's welfare lottery and sports lottery industries for more than 20 years, and is committed to bringing different innovative solutions to the industry, from lottery systems to interactive marketing then to the latest anti-counterfeiting solutions. The Group's new personal protective equipment business has also achieved rapid development. The Group has established 8 cleanrooms in Hong Kong and Mainland China, and more than 20 mask production lines have been put into operation since the beginning of 2020, producing 3-ply adult masks, 3-ply student masks, N95 folding masks, N95 cup-shaped masks and other personal protective equipment.

Listen
Download SPH RADIO APP
Last Played
Last Played